You are here:
Publication details
Sorafenib and sunitinib in metastatic renal cell carcinoma: Cost-effectiveness analysis in reimbursement proceedings vs. data from clinical practice
| Authors | |
|---|---|
| Year of publication | 2010 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation |